[Treatment of Parkinson's disease with L-dopa combined with a decarboxylase inhibitor].
D000818:Animals; D002262:Carboxy-Lyases / Q000037:antagonists & inhibitors*; D002986:Clinical Trials as Topic; D004295:Dihydroxyphenylalanine / Q000008:administration & dosage* / Q000009:adverse effects; D004357:Drug Synergism; D004794:Enzyme Repression; D006801:Humans; D009069:Movement Disorders / Q000188:drug therapy; D010300:Parkinson Disease / Q000188:drug therapy*
D004295:Dihydroxyphenylalanine; D002262:Carboxy-Lyases
Behandlung des Morbus Parkinson mit L-Dopa in Kombination mit einem Decarboxylasehemmer.